A Phase I clinical trial to study the safety of using Ayahuasca tea in healthy volunteers in a clinic setting.
With only a few participants, this study will test the effect of different doses of the medicine, to learn more about what happens to a person’s body during an Ayahuasca session.
This study will also help us understand how to optimize our approach to supporting patients through the Ayahuasca session.
Topic Healthy Subjects
Compound Ayahuasca
Country United States of America
Visit trial
Status
Planned
Results Published
Start date
01 December 2021
End date
01 June 2022
Chance of happening
60%
Phase
Phase I
Design
Open
Type
Observational
Generation
First
Participants
20
Sex
All
Therapy
No
Trial Details
We aim to give Ayahuasca in a group therapy setting. We choose group therapy, over individual therapy for multiple reasons - to provide more community support to patients in their healing journey, and to lower the cost of the therapy, to make it accessible to more people. We feel confident that giving Ayahuasca in a group setting will enhance the patient experience.NCT Number